Principal Investigator: Michael Keogh

Immune cells in the brain play a critical role in the progression of neurodegenerative disorders such as Alzheimer’s disease. Understanding how genetic mutations of these cells slow neurodegenerative disorders will help us develop new drugs for patients.

In this study, we determined how mutated cells slow the progression and development of neurodegeneration and  explored how these cells behave when exposed to conditions that we see in the brain with dementia.